|
Market Closed -
Nasdaq
23:00:00 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.860 USD | -1.87% |
|
+0.26% | +18.20% |
| 08-06 | Evolus, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Evolus, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOLUS, INC. | Other Pharmaceuticals | -1.87% | +0.26% | +18.20% | +22.43% | -4.38% | 519M |  |  | |
- Stock Market
- Stocks
- EOLS Stock
- Charts Evolus, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
